This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

New Technology From Smith & Nephew Offers More Efficient Uterine Fibroid Removal

LONDON, Dec. 18, 2012 /PRNewswire/ -- Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today introduced the newest addition to its innovative TRUCLEARâ„¢ System, the TRUCLEAR ULTRA Reciprocating Morcellator 4.0. Designed specifically for removing uterine fibroids, a health issue that will impact an estimated 80% of women i, this new device provides surgeons with a fast, efficient solution for a hysteroscopic procedure that can help patients avoid the possibility of a hysterectomy, or surgical removal of the uterus.

With a precision-engineered cutting edge and a uniquely designed tip that allows surgeons to access harder-to-reach fibroids, the TRUCLEAR ULTRA Reciprocating Morcellator 4.0 offers a resection rate more than twice that of the leading competitor (laboratory testing on analog tissue ii). Also, because TRUCLEAR ULTRA removes fibroids through hysteroscopic morcellation, or mechanical cutting, it requires no incisions or electrical energy to be used in the uterus and can be performed as an outpatient procedure.

"With the TRUCLEAR System, I have the confidence to safely and effectively resect submucosal fibroids and endometrial polyps under constant visualization," says David A. Stone, M.D., FACOG, who practices in metropolitan Detroit. "While using the TRUCLEAR ULTRA, I was able to remove a 2.5 centimeter diameter submucosal fibroid in a matter of a few minutes. Using this system can help preserve a woman's future fertility by minimizing damage to the uterus."

Uterine fibroids are estimated to cost the U.S. healthcare system over $6 billion every year iii. The most common surgical recommendation for these non-cancerous growths is to remove the uterus through a hysterectomy. For women, a hysterectomy means a hospital stay, four to eight weeks of recovery time, the added risk of infection, and the potential for long-term physical and psychological effects.

"Fibroids are one of the most significant diseases that women face," explains Mira Sahney, General Manager, Gynecology for Smith & Nephew. "Our new device offers a woman with uterine fibroids a considerably less invasive treatment option that may help preserve her ability to have children."

Smith & Nephew has a growing presence in the market to provide women with less-invasive treatment options for uterine care. The company continues to innovate in this area and provides surgeons with options for performing polypectomies and myomectomies safely and effectively under continuous, clear visualization.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.64 -0.11%
FB $118.57 0.84%
GOOG $698.21 0.75%
TSLA $241.80 0.43%
YHOO $36.53 -0.19%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs